Epigenomics AG 23.07.2019 / 11:00 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 […]
Year: 2019
23. July 2019
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
15. July 2019
Epigenomics AG: Chinese Patent Reexamination Department partially invalidates Epigenomics’ patent claims for Septin9
Epigenomics AG / Key word(s): Patent/Legal MatterEpigenomics AG: Chinese Patent Reexamination Department partially invalidates Epigenomics’ patent claims for Septin9 15-Jul-2019 / 15:49 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]
11. July 2019
Epigenomics AG Receives MedTech Outlook’s 2019 Top 10 In-Vitro Diagnostics Award
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 11.07.2019 / 14:30 The issuer is solely responsible for the content of this announcement. Epigenomics AG Receives MedTech Outlook’s 2019 Top 10 In-Vitro Diagnostics Award Company recognized for its leadership in advancing blood-based tests to diagnose cancer Berlin (Germany) and San Diego, CA (U.S.A.), July 11, 2019 – […]
19. June 2019
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG 19.06.2019 / 10:52 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 […]
17. June 2019
Epigenomics AG: New Clinical Data Support the Utility of Epi proColon(R) Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
DGAP-News: Epigenomics AG / Key word(s): Study results/Scientific publication 17.06.2019 / 14:00 The issuer is solely responsible for the content of this announcement. New Clinical Data Support the Utility of Epi proColon Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome Minimally-invasive blood test […]
04. June 2019
Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June
DGAP-News: Epigenomics AG / Key word(s): Conference 04.06.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June Berlin (Germany) and San Diego, CA (U.S.A.), June 4, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today […]